1. |
Hacke W, Schwab S, Horn M, et al. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol, 1996, 53(4): 309-315.
|
2. |
Kasner SE, Demchuk AM, Berrouschot J, et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke, 2001, 32(9): 2117-2123.
|
3. |
Michinaga S, Koyama Y. Pathogenesis of brain edema and investigation into anti-edema drugs. Int J Mol Sci, 2015, 16(5): 9949-9975.
|
4. |
Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2014, 45(4): 1222-1238.
|
5. |
Zhang Y, Liu G, Wang Y, et al. Procalcitonin as a biomarker for malignant cerebral edema in massive cerebral infarction. Sci Rep, 2018, 8(1): 993.
|
6. |
杨振宇. 降钙素原与 C 反应蛋白对西宁地区脑梗死继发脑水肿患者预后的影响. 西宁: 青海大学 , 2022.
|
7. |
季丽平, 张慧和, 陈炳, 等. 急性脑梗塞患者降钙素原水平与脑水肿严重程度的相关性研究. 中国卫生检验杂志, 2020, 30(1): 12-14.
|
8. |
陈广鹏, 苗国印, 杨艳琴. 急性脑梗死患者血清 VEGF、PCT、hs-CRP 表达与脑水肿严重程度的关系. 临床荟萃, 2021, 36(4): 315-318.
|
9. |
Wu S, Yuan R, Wang Y, et al. Early prediction of malignant brain edema after ischemic stroke. Stroke, 2018, 49(12): 2918-2927.
|
10. |
马蓉, 栾飞, 李茂星, 等. 炎性因子在脑水肿发病机制中的作用. 西北国防医学杂志, 2015, 36(7): 465-468.
|
11. |
Simard JM, Kent TA, Chen M, et al. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol, 2007, 6(3): 258-268.
|
12. |
Weisenburger-Lile D, Dong Y, Yger M, et al. Harmful neutrophil subsets in patients with ischemic stroke: association with disease severity. Neurol Neuroimmunol Neuroinflamm, 2019, 6(4): e571.
|
13. |
Ng FC, Churilov L, Yassi N, et al. Microvascular dysfunction in blood-brain barrier disruption and hypoperfusion within the infarct posttreatment are associated with cerebral edema. stroke, 2022, 53(5): 1597-1605.
|
14. |
李佳楠, 李立宏. 缺血性脑卒中后脑水肿的发病机制及治疗进展. 临床医学进展, 2024, 14(4): 2769-2778.
|
15. |
Miyakis S, Georgakopoulos P, Kiagia M, et al. Serial serum procalcitonin changes in the prognosis of acute stroke. Clin Chim Acta, 2004, 350(1/2): 237-239.
|
16. |
Li YM, Liu XY. Molecular mechanisms underlying application of serum procalcitonin and stool miR-637 in prognosis of acute ischemic stroke. Am J Transl Res, 2016, 8(10): 4242-4249.
|
17. |
Ibrahim F, Menezes S, Buhnerkempe M, et al. Systemic white blood cell count as a biomarker for malignant cerebral edema in large vessel ischemic MCA stroke. J Stroke Cerebrovasc Dis, 2022, 31(8): 106550.
|